OLO. V. Lerman

O. V. Lerman

*This is an algorithmically generated author record based on publicly available information.

O. V. Lerman has a total of 145 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in the prognostic value of diabetes in patients after cerebrovascular accident during long-term follow-up: data from the REGION-M registry

    by V. P. Voronina, A. V. Zagrebelny, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, O. V. Lerman, M. M. Lukyanov, S. Yu. Martsevich, O. M. Drapkina, В. П. Воронина, et al.

    Aim . To evaluate the prognostic value of type 2 diabetes (T2D) and to study the relationship between T2D and the risk of mortality at different stages of long-term outpatient follow-up in patients with cerebrovascular accidents (CVA). Material and methods . Within the registry of patients who suffered a stroke in 2012-2017, medical records and discharge summaries after the reference stroke (n=900), as well as outpatient records of patients (n=684), were analyzed. During the outpatient phase of follow-up completed in 2025 within the prospective part of the REGION-M registry, the long-term prognosis of patients after stroke was assessed and the role of type 2 diabetes as a possible prognostic factor was determined at various follow-up stages (2017-2025). The primary endpoint was all-cause death. Results . The entire outpatient phase of observation was divided into four following stages: Stage 1 (median (Me) 22 [13; 38] months) — from the reference stroke to hospital discharge (2017); Stage 2 (Me 57 [45; 71] months) — outpatient follow-up (2017-2020); Stage 3 (Me 79 [68; 95] months) — outpatient follow-up (2020-2022); Stage 4 (Me 114 [103; 128] months) — outpatient follow-up (2022-2025). The median total follow-up time was 9,5 years, during this period. In general, no significant differences in survival were found in patients depending on T2D: hazard ratio (HR) =1,24; 95% confidence interval (CI): 0,985-1,567 (p=0,067), however, Piecewise Cox Regression confirmed a significant association between T2D and the death risk in patients with a history of stroke at stages 1 and 3 of outpatient follow-up as follows: direct association at stage 1 and inverse association at stage 3 (HR=0,67, 95% CI: 0,45-0,99, p=0,044 and HR=1,70 95% CI: 1,07-2,71, p=0,026). Conclusion . In the prospective REGION-M registry part, the long-term prognosis of patients with a history of stroke was assessed at various time points. T2D has an independent negative prognostic value at certain stages of long-term follow-up of such patients.

  • Open Access

    The STOKS acute coronary syndrome registry with online information monitoring: the problem of missing data

    by S. Yu. Martsevich, А. В. Загребельный, P. A. Zolotarev, И. О. Алиев, N. P. Kutishenko, V. P. Voronina, Н. А. Дмитриевна, O. V. Lerman, Yu. V. Lukina, E. P. Kalaydzhyan, et al.

    Aim. To analyze the frequency of missing data on the time of pain onset, obtained from medical records and patient questionnaires for acute coronary syndrome (ACS), and to evaluate the factors associated with this missing data. Material and methods. The study was conducted as part of the prospective Stupino Registry of ACS (STOCS), which has included all consecutive patients with ACS or suspected ACS admitted to the regional vascular center since January 10, 2025. Data on the time of angina pain onset were obtained from information in medical records and patient questionnaires. Results. Data from 261 patients included in the registry for the first 6 months of 2025 were analyzed. Referral diagnoses and diagnoses established upon hospital admission did not comply with current clinical guidelines in almost a third of patients. An analysis of patient records revealed that data on the angina onset was available for only 212 patients and missing for 49 (18,8%). Analysis of questionnaires completed by patients revealed missing information on pain onset in 3,1% of cases. The following factors were associated with missing data in patient records: older age, ST-segment elevation, and prior cerebrovascular accident. Older age and inhospital death were also associated with missing information in patient records. Conclusion. The study results showed that missing data on the pain onset was present in almost one in five patient records and in only 3% of structured questionnaires completed by patients. The lack of information about the pain onset in medical records and patient questionnaires is not accidental and is associated with a number of factors (advanced age, prior cerebrovascular accident, and inhospital death). Missing data on pain onset can be partially filled in through a structured patient survey, but it is virtually impossible to completely eliminate these omissions.


  • Open Access

    A patient with overweight or obesity: lessons from COVID-19 pandemic (EVA observational study data)

    by Ю. В. Лукина, О. В. Лерман, N. P. Kutishenko, С. Ю. Марцевич, О. М. Драпкина От Имени Рабочей Группы Исследования Ева, S. Yu. Martsevich

    Aim . To evaluate the health status and outcomes of patients with overweight (pre-obesity) or obesity during long-term follow-up as part of the EVA observational program. Material and methods . The EVA study included patients with over­weight and obesity (body mass index (BMI) >25 kg/m 2 ) from the out­patient registry of patients with cardiovascular diseases or their risk fac­tors from April 8, 2019 to March 24, 2020. One and three years after the enrollment visit (coinciding with the COVID-19 pandemic), we con­tacted patients by telephone to collect information on body weight at the survey date, medication adherence, and subjective assessment of pre-obesity/obesity. At the three-year follow-up, data were collected on COVID-19 history and the changes of comorbid conditions during the COVID-19 pandemic. Results . The study included 295 patients. The mean follow-up period was 3,6±0,5 years. The second telephone contact yielded following information on 261 (88,5%) patients: 18 — died, 243 — alive. In ad­dition, 129 (43,7%) patients had COVID-19. Adherent patients and older people were less susceptible to the risk of COVID-19 infection compared to non-adherent and younger patients (p=0,016 and p=0,043, respectively). Every third (32,3%) patient who had COVID-19 experienced worsening of noncommunicable diseases (NCDs), and almost every fourth (23,4%) patient developed new-onset NCDs. A decrease in weight self-assessment criticality was found, especially in patients with pre-obesity, 40% of whom considered their body weight to be normal. Predictors of adverse outcomes were prior myocardial infarction (hazard ratio (HR)=6,10; 95% confidence interval (CI): 1,18-31,46 (p=0,031)), type 2 diabetes (HR=2,78; 95% CI: 1,03-7,51, p=0,043) and BMI (HR=1,12; 95% CI: 1,01-1,24 (p=0,035)). Conclusion . Significant predictors of an unfavorable prognosis in patients over a 3-year follow-up period were elevated BMI, prior myocardial infarction, and diabetes. After COVID-19, one-third of pa­tients experienced progression of existing noncommunicable diseases, and one in four patients developed a new-onset NCDs. Non-adherence was one of two factors associated with COVID-19 in­fec­tion. During the COVID-19 pandemic, a slight decrease in weight self-as­sessment criticality was noted in patients with pre-obesity or obesity.

  • Open Access

    Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry)

    by N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, et al.

    Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD) at the remote stage of follow-up after hospitalization for new coronavirus infection (COronaVIrus Disease 2019, COVID-19) within the framework of the prospective TARGET-VIP registry.Material and methods. 1,130 people were included in the registry. The 473 (54.8%) patients with CVD were selected of the 863 patients discharged from the hospital with a diagnosis of COVID-19.Results. The frequency of proper prescriptions of medicines upon discharge from the hospital was 60%, after 3 years this indicator decreased to 41.4% (pConclusion. The quality of CVD therapy was insufficient at all stages of long-term follow-up: the frequency of proper prescriptions upon discharge from the hospital was 60%, after 3 years this indicator decreased to 41.4%. A clear trend was revealed in a decrease in the frequency of taking all drugs, while for some groups of drugs this decrease reached statistically significant differences. The quality of cardiovascular pharmacotherapy was higher with the appearance / development of new CVD in comparison with the group of stable patients with CVD, there was no significant improvement in the quality of therapy for previously observed CVD.

  • Open Access

    Long-term prognosis of life in patients with cerebrovascular accident: the role of diabetes mellitus (according to the REGION-M registry outpatient follow-up phase)

    by V. P. Voronina, A. V. Zagrebelny, Yu. V. Lukina, S. N. Tolpygina, N. P. Kutishenko, M. I. Chernysheva, M. M. Lukyanov, N. A. Dmitrieva, O. V. Lerman, S. Yu. Martsevich, et al.

    Aim. To study the long-term prognosis of patients’ life who have suffered cerebrovascular accident (CVA), and to determine the role of diabetes mellitus (DM) as a possible negative prognostic factor, according to the outpatient follow-up stage in the REGION-M registry.Material and methods. The outpatient part of the REGION-M registry included 684 patients assigned to the Moscow City Polyclinic No. 64, discharged from the hospital in the period from 01.01.2012 to 30.04.2017 with a confirmed diagnosis of CVA, of which 122 patients (17.8%) were diagnosed with DM. The polyclinic stage included three observation points: 2017, 2020, and 2022. Data on the life status of all patients were obtained by telephone survey, if it was impossible to establish contact with the patient or his relatives, a unified medical information and analytical system was used to determine the life status of patients. The study patients were observed on an outpatient basis for more than 5 years (ME 1958 (751; 2555) days), the primary endpoint was death from any cause.Results. Information about the life status was obtained for all 684 patients. By the end of the observation, 415 cohort members had died, and 269 were alive. The average age of patients with DM was significantly higher than that of patients without DM: 71.5±10.9 years vs 68.0±14.7 years (pConclusion. In the long-term follow-up of patients with CVA, there was no statistically significant adverse effect of DM on long-term survival.


  • Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data)

    by M.M. Loukianov, S.YU. Martsevich, N.P. Kutishenko, E.YU. Andreenko, V.P. Voronina, V.A. Dindikova, N.A. Dmitrieva, M.M. Kudryavtseva, O.V. Lerman, A.N. Makoveeva, et al.

    Objective. To assess the distant outcomes during three-year post-hospital follow-up of patients after in-patient care for COronaVIrus Disease 2019 (COVID-19) in a prospective registry. Materials and methods. Outcomes for 3.2±0.7 years of follow-up after hospitalization for COVID-19 were analyzed in 836 patients (age 60.2±14.7 years, 51.2% were males). Cases of death, development of non-fatal myocardial infarction (MI) and non-fatal cerebral stroke (CS), hospitalizations, recurrent COVID-19 were evaluated. Results. During the follow-up period, 63 (7.5%) patients died, 8 (0.96%) cases of MI were registered and 9 (1.1%) — CS, 270 (32.3%) patients were hospitalized, 174 (20.8%) re-suffered COVID-19. Patients with cardiovascular multimorbidity had higher mortality (by a factor of 7), incidence of non-fatal MI and CS, hospitalization than in persons without cardiovascular diseases (CVDs). Male sex is associated with risk of death: HR=2.077, p=0.007. Factors of age, intensive care unit stay during reference hospitalization are associated (p<0.005) not only with the risk of death from all causes (hazard ratio (HR)=1.065 and HR=4.2, respectively), but also with the risk of composite endpoint development (death, non-fatal MI and CS, revascularization procedures): odds ratio (OR)=1.033 and OR=1.85. Hospitalization is associated with older age (OR)=1.027; p<0.001), presence of CVDs (OR=1.66; p=0.01) and chronic non-cardiac diseases (OR=1.51; p=0.013). Risk of developing new CVDs and non-cardiac diseases is associated with older age (OR=1.02; p=0.03). Risk of COVID-19 recurrent cases is higher in presence of CVDs (HR=1.62; p=0.011), lower in persons vaccinated against SARS-CoV-2 (HR=0.55; p<0.001). Higher acute upper respiratory infections morbidity is associated (p<0.001) with younger age and lack of non-cardiac multimorbidity. Conclusion. The proportion of dead amounted to 7.5% for 3 years of post-hospital follow-up of patients for COVID-19, hospitalizations and COVID-19 recurrent cases were the most frequent events. Mortality was 7 times higher in the group with cardiovascular multimorbidity than in persons without cardiovascular diseases. Factors associated with the fatal outcome development were the following: age, cardiovascular and non-cardiac multimorbidity, treatment in the intensive care unit during reference hospitalization. Risk of re-hospitalization for any cause is associated with older age, presence of cardiovascular diseases and non-cardiac diseases. Risk of COVID-19 recurrent cases was 1.5 times higher in presence of cardiovascular diseases, but almost 2 times lower in vaccinated against SARS-CoV-2 subjects in the post-COVID period.


  • Long-term outcomes in patients with cardiovascular multimorbidity suffered from COVID-19: two-year observation

    by A.A. Smirnov, M.M. Loukianov, S.YU. Martsevich, N.P. Kutishenko, E.YU. Andreenko, V.P. Voronina, V.A. Dindikova, N.A. Dmitrieva, M.M. Kudryavtseva, O.V. Lerman, et al.

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить отдаленные исходы и статус у пациентов с кардиоваскулярной мультиморбидностью (КВММ) в сравнении с пациентами без сердечно-сосудистых заболеваний (ССЗ) через 2 года после госпитализации по поводу COVID-19. МАТЕРИАЛ И МЕТОДЫ В регистре ТАРГЕТ-ВИП у пациентов с подтвержденным в стационаре диагнозом COVID-19 КВММ была определена как наличие двух и более из следующих ССЗ: артериальная гипертония (АГ), ишемическая болезнь сердца (ИБС), хроническая сердечная недостаточность (ХСН), фибрилляция предсердий (ФП). Группу с КВММ составили 163 человека (возраст 73,7±9,6 года; 53,9% мужчин), а группу без ССЗ — 382 человека (возраст 49,4±12,4 года; 58,4% мужчин). Через 28,1±4,6 мес из репрезентативной выборки выживших пациентов опрошены и обследованы 27 пациентов с КВММ (возраст 73,2±9,9 года; 44,4% мужчин) и 144 пациента без ССЗ (возраст 52,2±10,8 года; 52,1% мужчин). Исходная информация получена из историй болезни, а при наблюдении — по результатам телефонных опросов пациентов за период 24 мес, амбулаторных визитов и из электронных баз данных. РЕЗУЛЬТАТЫ У пациентов с КВММ по сравнению с группой без ССЗ были выше смертность от всех причин (19,0% и 3,1%; p=0,001), частота случаев госпитализации (49,7% и 16,5%; p=0,001), однако частота случаев острой респираторной вирусной инфекции (ОРВИ) / гриппа была ниже (44,8% и 64,7%; p1/ФЖЕЛ (p=0,0002). По данным пульсоксиметрии, показатель SpO2 менее 95% перед спирометрией выявлялся чаще у пациентов с КВММ (14,8% и 4,2%; p=0,03), а за все время проведения спирометрии — в 3 раза чаще (25,9% по сравнению с 8,4%; p=0,008). У больных с КВММ частота выявления патологических изменений в легких при мультиспиральной компьютерной томографии (МСКТ) была в 2,2 раза выше (57,7% по сравнению с 26,5%; p=0,002). ЗАКЛЮЧЕНИЕ У перенесших COVID-19 пациентов с КВММ по сравнению с пациентами без ССЗ за 24 мес наблюдения были выше следующие показатели: доля случаев смерти от всех причин (в 6,1 раза), частота случаев нефатальных инфаркта миокарда и мозгового инсульта, частота случаев госпитализации (в 3 раза), но меньше частота ОРВИ/гриппа (в 1,4 раза). Пациенты без ССЗ были более привержены вакцинации против SARS-CoV-2. У пациентов с КВММ, по результатам спирометрии и мониторирования пульсоксиметрии, чаще встречалось снижение показателей функции внешнего дыхания и SpO2. Частота выявления патологии легких при МСКТ была в 2,2 раза выше у пациентов с КВММ.


  • Comorbidity and long-term survival of patients suffered from acute cerebrovascular accident based on the REGION-M registry

    by S.N. Tolpygina, A.V. Zagrebelny, M.I. Chernysheva, N.P. Kutishenko, Yu.V. Lukina, V.P. Voronina, N.A. Dmitrieva, O.V. Lerman, M.M. Lukyanov, E.YU. Okshina, et al.

    ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить влияние коморбидных заболеваний на отдаленную выживаемость больных, перенесших острое нарушение мозгового кровообращения (ОНМК). МАТЕРИАЛ И МЕТОДЫ В амбулаторную часть регистра РЕГИОН-М включены 684 пациента, прикрепленных к ГБУЗ города Москвы «Городская поликлиника №64 Департамента здравоохранения города Москвы», выписанных из ГБУЗ города Москвы «Городская клиническая больница им. Ф.И. Иноземцева Департамента здравоохранения города Москвы» в период с 01.01.12 по 30.04.17 с подтвержденным диагнозом ОНМК (инсульт или транзиторная ишемическая атака). Амбулаторный этап наблюдения с 2017 по 2022 г. составил 5,5 (2,4—7,0) года. В качестве конечной точки выбрана «смерть от всех причин». РЕЗУЛЬТАТЫ В однофакторном анализе негативное влияние на прогноз имели наличие ишемической болезни сердца (p<0,0001), перенесенный инфаркт миокарда (p<0,0001), наличие сахарного диабета (p<0,05) и ожирения (p<0,01). В многофакторном анализе, включающем, помимо коморбидных заболеваний, пол и возраст, статистическую значимость сохранил только перенесенный инфаркт миокарда в анамнезе (ОР смерти 1,009 (95%ДИ 1,004—1,014, p<0,001). ЗАКЛЮЧЕНИЕ У пациентов, перенесших ОНМК, отдаленную выживаемость ухудшало только наличие инфаркта миокарда в анамнезе.


  • Open Access

    Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry

    by M. M. Lukyanov, E. Yu. Andreenko, S. Yu. Martsevich, N. P. Kutishenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, et al.

    Aim. To evaluate 24-month outcomes after hospital treatment of patients with coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. Two-year outcomes (2,2±0,5) after hospital treatment for COVID-19 were analyzed in 802 patients (mean age, 59,8±14,5 years, men, 51,0%). We assessed cases of death, non-fatal myocardial infarction (MI) and stroke, revascularization operations, hospitalizations, recurrent COVID-19, vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Results. During the follow-up period, 49 (5,9%) patients died, while 7 (0,8%) patients had MI, 7 (0,8%) — stroke. In addition, 222 (26,7%) patients were hospitalized, of which 26 (3,1%) for COVID-19. Recurrent COVID-19 were revealed in 146 (17,6%) patients, while 414 (49,6%) patients were vaccinated for SARS-CoV-2. The factors of age and stay in the intensive care unit were significantly associated (p2/3 during the first year. Factors associated with death were age, male sex, and intensive care unit treatment during the hospitalization. The readmission rate was associated with older age and CVDs. The risk of repeated cases of COVID-19 was one and a half times higher in the presence of CVDs, but 2 times lower in those vaccinated for SARS-CoV-2 in the post- COVID-19 period.


  • Open Access

    Medical follow-up and long-term survival of patients with cerebrovascular accident: data from the REGION-M registry

    by S. N. Tolpygina, M. I. Chernysheva, А. В. Загребельный, V. P. Voronina, N. P. Kutishenko, N. A. Dmitrieva, O. V. Lerman, Yu. V. Lukina, M. M. Lukyanov, E. Yu. Okshina, et al.

    Aim. To assess the survival rate of patients after cerebrovascular accident (CVA), depending on the visits to the local outpatient clinic and the type of medical supervision, and in the first year after hospital discharge. Material and methods . The outpatient part of the REGION-M registry included 684 patients assigned to the City Polyclinic № 64 of Moscow, discharged from the F. I. Inozemtsev City Clinical Hospital (Moscow) in the period from January 1, 2012 to April 30, 2017 with a confirmed diagnosis of cerebral stroke/transient ischemic attack. Results. During the first year after the CVA, 451 (65,9%) patients visited the local clinic on their own (group 1), while 166 (24,3%) patients was consulted by house call (group 2), and 67 (9,8%) did not see the physician (group 3). Patients visited by house call were more likely to have prior coronary artery disease and stroke, and the age of men was older than in other groups. Patients who did not see a doctor were less likely to have comorbidities and disabilities, and were less likely to visit the clinic before stroke. The mortality of patients in group 3 was significantly higher throughout the entire follow-up period (55,2%, 70,1% and 77,6% at stages 1, 2 and 3 (pConclusion. The lower mortality among those visited the local clinic in the first year after CVA and among those who were visited by a doctor at home, compared with patients who were not observed, confirms the important role of medical supervision in the post-hospital period.